Charles Austin Morris, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Infectious Disease Transmission, Patient-to-Professional | 2 | 2021 | 253 | 0.770 |
Why?
|
| Mandatory Programs | 1 | 2021 | 87 | 0.750 |
Why?
|
| Receptors, Phospholipase A2 | 1 | 2018 | 33 | 0.640 |
Why?
|
| Renal Veins | 1 | 2018 | 108 | 0.630 |
Why?
|
| Cross Infection | 3 | 2021 | 1416 | 0.600 |
Why?
|
| Glomerulonephritis, Membranous | 1 | 2018 | 86 | 0.590 |
Why?
|
| Infection Control | 3 | 2021 | 966 | 0.590 |
Why?
|
| Grief | 1 | 2019 | 247 | 0.580 |
Why?
|
| Mentors | 1 | 2019 | 631 | 0.480 |
Why?
|
| Wounds, Gunshot | 1 | 2018 | 563 | 0.410 |
Why?
|
| Interpersonal Relations | 1 | 2019 | 1425 | 0.400 |
Why?
|
| Health Education | 1 | 2018 | 1056 | 0.390 |
Why?
|
| Occupational Exposure | 1 | 2021 | 1796 | 0.380 |
Why?
|
| Pneumonia, Viral | 4 | 2021 | 3240 | 0.370 |
Why?
|
| Firearms | 1 | 2018 | 598 | 0.370 |
Why?
|
| Health Policy | 1 | 2021 | 2661 | 0.330 |
Why?
|
| Venous Thrombosis | 1 | 2018 | 1239 | 0.330 |
Why?
|
| Masks | 2 | 2020 | 197 | 0.310 |
Why?
|
| Health Personnel | 1 | 2021 | 3218 | 0.310 |
Why?
|
| Osteoporosis | 3 | 2006 | 1580 | 0.290 |
Why?
|
| Physician-Patient Relations | 1 | 2019 | 3229 | 0.270 |
Why?
|
| Pulmonary Embolism | 1 | 2018 | 2376 | 0.260 |
Why?
|
| Patient Discharge | 5 | 2024 | 3313 | 0.240 |
Why?
|
| Estrogen Receptor Modulators | 1 | 2003 | 61 | 0.230 |
Why?
|
| Estrogen Antagonists | 1 | 2003 | 152 | 0.220 |
Why?
|
| Plant Preparations | 1 | 2003 | 94 | 0.220 |
Why?
|
| Water Purification | 1 | 2023 | 48 | 0.220 |
Why?
|
| Marketing | 1 | 2003 | 212 | 0.200 |
Why?
|
| Thoracic Vertebrae | 1 | 2006 | 608 | 0.200 |
Why?
|
| Beds | 1 | 2020 | 48 | 0.180 |
Why?
|
| Respiration Disorders | 1 | 2022 | 371 | 0.170 |
Why?
|
| Spinal Fractures | 1 | 2006 | 696 | 0.170 |
Why?
|
| Pharmacists | 1 | 2021 | 248 | 0.160 |
Why?
|
| Pandemics | 5 | 2021 | 8388 | 0.160 |
Why?
|
| Nitriles | 1 | 2003 | 956 | 0.160 |
Why?
|
| Coronavirus Infections | 3 | 2020 | 3133 | 0.160 |
Why?
|
| Triazoles | 1 | 2003 | 911 | 0.150 |
Why?
|
| Utilization Review | 1 | 2019 | 392 | 0.150 |
Why?
|
| Respiratory Tract Diseases | 1 | 2022 | 722 | 0.150 |
Why?
|
| Attitude to Death | 1 | 2019 | 382 | 0.140 |
Why?
|
| Hospitals | 4 | 2023 | 3952 | 0.140 |
Why?
|
| Inservice Training | 2 | 2019 | 392 | 0.140 |
Why?
|
| Hospice Care | 1 | 2023 | 672 | 0.140 |
Why?
|
| Home Care Services | 1 | 2022 | 606 | 0.140 |
Why?
|
| Estradiol | 1 | 2003 | 2020 | 0.130 |
Why?
|
| Unnecessary Procedures | 1 | 2019 | 432 | 0.130 |
Why?
|
| Information Dissemination | 1 | 2003 | 1099 | 0.130 |
Why?
|
| Antineoplastic Agents, Hormonal | 1 | 2003 | 1524 | 0.130 |
Why?
|
| Nephrotic Syndrome | 1 | 2018 | 389 | 0.120 |
Why?
|
| Infertility | 1 | 2021 | 655 | 0.120 |
Why?
|
| Safety Management | 1 | 2020 | 783 | 0.120 |
Why?
|
| Edema | 1 | 2018 | 789 | 0.120 |
Why?
|
| Continuity of Patient Care | 1 | 2021 | 1049 | 0.120 |
Why?
|
| Inpatients | 5 | 2023 | 2518 | 0.120 |
Why?
|
| Academic Medical Centers | 2 | 2024 | 2759 | 0.120 |
Why?
|
| Influenza Vaccines | 1 | 2021 | 738 | 0.120 |
Why?
|
| Boston | 3 | 2021 | 9313 | 0.120 |
Why?
|
| Medical Order Entry Systems | 1 | 2019 | 545 | 0.110 |
Why?
|
| Government Regulation | 1 | 2018 | 522 | 0.110 |
Why?
|
| Communicable Disease Control | 1 | 2020 | 857 | 0.110 |
Why?
|
| Leg | 1 | 2018 | 1116 | 0.110 |
Why?
|
| Diabetes Insipidus | 2 | 2010 | 151 | 0.110 |
Why?
|
| Abdominal Pain | 1 | 2018 | 1063 | 0.100 |
Why?
|
| Terminal Care | 1 | 2023 | 1694 | 0.100 |
Why?
|
| Emergency Service, Hospital | 2 | 2022 | 7659 | 0.100 |
Why?
|
| Disease Outbreaks | 1 | 2021 | 1772 | 0.100 |
Why?
|
| Bone Density | 1 | 2004 | 3468 | 0.100 |
Why?
|
| Internet | 1 | 2003 | 3064 | 0.100 |
Why?
|
| Mass Screening | 2 | 2020 | 5255 | 0.100 |
Why?
|
| Dietary Supplements | 1 | 2003 | 3297 | 0.090 |
Why?
|
| Humans | 29 | 2024 | 744343 | 0.090 |
Why?
|
| Hospitalization | 4 | 2022 | 10262 | 0.090 |
Why?
|
| Influenza, Human | 1 | 2021 | 1479 | 0.090 |
Why?
|
| Autoantibodies | 1 | 2018 | 2035 | 0.090 |
Why?
|
| United States | 7 | 2023 | 69872 | 0.090 |
Why?
|
| Adrenal Insufficiency | 1 | 2010 | 184 | 0.080 |
Why?
|
| Hypopituitarism | 1 | 2010 | 254 | 0.080 |
Why?
|
| Cardiac Surgical Procedures | 1 | 2023 | 3537 | 0.080 |
Why?
|
| Suicide | 1 | 2018 | 1477 | 0.070 |
Why?
|
| Female | 15 | 2024 | 380194 | 0.070 |
Why?
|
| Diagnosis, Differential | 3 | 2018 | 12959 | 0.070 |
Why?
|
| Leadership | 1 | 2015 | 1357 | 0.070 |
Why?
|
| Adult | 8 | 2022 | 214055 | 0.060 |
Why?
|
| Diagnostic Imaging | 1 | 2019 | 3507 | 0.060 |
Why?
|
| Analgesics, Opioid | 1 | 2021 | 3674 | 0.060 |
Why?
|
| Densitometry | 1 | 2004 | 156 | 0.060 |
Why?
|
| Breast Neoplasms | 3 | 2010 | 20822 | 0.060 |
Why?
|
| Physicians | 1 | 2022 | 4567 | 0.060 |
Why?
|
| Asthma | 1 | 2022 | 6011 | 0.060 |
Why?
|
| Outpatient Clinics, Hospital | 1 | 2006 | 392 | 0.060 |
Why?
|
| Case-Control Studies | 1 | 2021 | 21746 | 0.060 |
Why?
|
| Anticoagulants | 1 | 2018 | 4599 | 0.050 |
Why?
|
| Anemia, Iron-Deficiency | 1 | 2007 | 365 | 0.050 |
Why?
|
| Erythropoietin | 1 | 2007 | 726 | 0.050 |
Why?
|
| Electronic Health Records | 1 | 2019 | 4468 | 0.050 |
Why?
|
| Carcinoma, Ductal, Breast | 1 | 2010 | 1101 | 0.050 |
Why?
|
| Ice | 1 | 2023 | 104 | 0.050 |
Why?
|
| Radiology Department, Hospital | 1 | 2006 | 412 | 0.050 |
Why?
|
| Hydrocortisone | 1 | 2010 | 1826 | 0.050 |
Why?
|
| Legislation, Drug | 1 | 2003 | 206 | 0.050 |
Why?
|
| Aged | 8 | 2022 | 163280 | 0.050 |
Why?
|
| Pituitary Neoplasms | 1 | 2010 | 1345 | 0.050 |
Why?
|
| Hydromorphone | 1 | 2021 | 65 | 0.050 |
Why?
|
| Incidental Findings | 1 | 2006 | 689 | 0.050 |
Why?
|
| Visitors to Patients | 1 | 2020 | 35 | 0.050 |
Why?
|
| Medical Records | 1 | 2006 | 1413 | 0.050 |
Why?
|
| Drug Compounding | 1 | 2021 | 242 | 0.050 |
Why?
|
| Hospitals, Community | 1 | 2022 | 348 | 0.040 |
Why?
|
| Documentation | 1 | 2006 | 871 | 0.040 |
Why?
|
| Feedback | 1 | 2023 | 795 | 0.040 |
Why?
|
| Lung | 1 | 2018 | 9856 | 0.040 |
Why?
|
| Radiography, Thoracic | 1 | 2006 | 1265 | 0.040 |
Why?
|
| Personnel, Hospital | 1 | 2021 | 283 | 0.040 |
Why?
|
| Middle Aged | 9 | 2022 | 213383 | 0.040 |
Why?
|
| Severe Acute Respiratory Syndrome | 1 | 2020 | 137 | 0.040 |
Why?
|
| Male | 8 | 2022 | 350118 | 0.040 |
Why?
|
| Crowding | 1 | 2020 | 145 | 0.040 |
Why?
|
| Lymphatic Diseases | 2 | 2010 | 324 | 0.040 |
Why?
|
| Coronavirus | 1 | 2020 | 158 | 0.040 |
Why?
|
| Peer Review | 1 | 2020 | 209 | 0.040 |
Why?
|
| Practice Guidelines as Topic | 2 | 2005 | 7279 | 0.040 |
Why?
|
| Hospitals, University | 1 | 2019 | 571 | 0.040 |
Why?
|
| Health Plan Implementation | 1 | 2020 | 352 | 0.040 |
Why?
|
| United States Food and Drug Administration | 1 | 2003 | 1584 | 0.030 |
Why?
|
| Fatal Outcome | 2 | 2010 | 1850 | 0.030 |
Why?
|
| Risk Factors | 2 | 2021 | 72290 | 0.030 |
Why?
|
| Internship and Residency | 1 | 2015 | 5788 | 0.030 |
Why?
|
| Kidney Failure, Chronic | 1 | 2007 | 2538 | 0.030 |
Why?
|
| Workflow | 1 | 2019 | 847 | 0.030 |
Why?
|
| Postmenopause | 1 | 2003 | 2461 | 0.030 |
Why?
|
| Delivery of Health Care | 2 | 2024 | 5319 | 0.030 |
Why?
|
| Retrospective Studies | 4 | 2022 | 77449 | 0.030 |
Why?
|
| Patient Education as Topic | 1 | 2003 | 2278 | 0.030 |
Why?
|
| User-Computer Interface | 1 | 2019 | 1431 | 0.030 |
Why?
|
| Patient Admission | 1 | 2020 | 1380 | 0.030 |
Why?
|
| Acute Disease | 1 | 2022 | 7149 | 0.030 |
Why?
|
| Antidiuretic Agents | 1 | 2010 | 24 | 0.020 |
Why?
|
| Polyuria | 1 | 2010 | 39 | 0.020 |
Why?
|
| Aged, 80 and over | 3 | 2022 | 57776 | 0.020 |
Why?
|
| Deamino Arginine Vasopressin | 1 | 2010 | 91 | 0.020 |
Why?
|
| Adolescent | 1 | 2018 | 85781 | 0.020 |
Why?
|
| Xerostomia | 1 | 2010 | 95 | 0.020 |
Why?
|
| Hospital Mortality | 1 | 2023 | 5317 | 0.020 |
Why?
|
| Hypernatremia | 1 | 2010 | 82 | 0.020 |
Why?
|
| Anorexia | 1 | 2010 | 161 | 0.020 |
Why?
|
| Double-Blind Method | 1 | 2003 | 12026 | 0.020 |
Why?
|
| Patient Care Team | 1 | 2020 | 2531 | 0.020 |
Why?
|
| Critical Care | 1 | 2021 | 2647 | 0.020 |
Why?
|
| Patient Readmission | 1 | 2022 | 3114 | 0.020 |
Why?
|
| Longitudinal Studies | 1 | 2024 | 13989 | 0.020 |
Why?
|
| Dizziness | 1 | 2010 | 251 | 0.020 |
Why?
|
| Muscle Weakness | 1 | 2010 | 413 | 0.020 |
Why?
|
| Disease Progression | 1 | 2003 | 13284 | 0.020 |
Why?
|
| Drug Utilization Review | 1 | 2007 | 245 | 0.020 |
Why?
|
| Hematocrit | 1 | 2007 | 636 | 0.020 |
Why?
|
| Incidence | 1 | 2020 | 20947 | 0.010 |
Why?
|
| Lymphatic Metastasis | 1 | 2010 | 2924 | 0.010 |
Why?
|
| Treatment Outcome | 2 | 2005 | 63114 | 0.010 |
Why?
|
| Receptor, erbB-2 | 1 | 2010 | 2416 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2020 | 23338 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2003 | 53288 | 0.010 |
Why?
|
| Radiography | 1 | 2010 | 7023 | 0.010 |
Why?
|
| Iron | 1 | 2007 | 1774 | 0.010 |
Why?
|
| Drug Utilization | 1 | 2005 | 1183 | 0.010 |
Why?
|
| Lymph Nodes | 1 | 2010 | 3474 | 0.010 |
Why?
|
| Time Factors | 1 | 2020 | 40075 | 0.010 |
Why?
|
| Biopsy | 1 | 2010 | 6756 | 0.010 |
Why?
|
| Recombinant Proteins | 1 | 2007 | 6622 | 0.010 |
Why?
|
| Young Adult | 1 | 2020 | 56430 | 0.010 |
Why?
|
| Fractures, Bone | 1 | 2005 | 1947 | 0.010 |
Why?
|
| Patient Selection | 1 | 2005 | 4215 | 0.010 |
Why?
|
| Sex Factors | 1 | 2005 | 10397 | 0.010 |
Why?
|
| Age Factors | 1 | 2005 | 18370 | 0.000 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2010 | 20129 | 0.000 |
Why?
|
| Brain | 1 | 2010 | 26385 | 0.000 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2010 | 35421 | 0.000 |
Why?
|